000 01452 a2200397 4500
005 20250516210633.0
264 0 _c20140922
008 201409s 0 0 eng d
022 _a2326-5205
024 7 _a10.1002/art.38674
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWang, Dandan
245 0 0 _aA CD8 T cell/indoleamine 2,3-dioxygenase axis is required for mesenchymal stem cell suppression of human systemic lupus erythematosus.
_h[electronic resource]
260 _bArthritis & rheumatology (Hoboken, N.J.)
_cAug 2014
300 _a2234-45 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aCD8-Positive T-Lymphocytes
_xphysiology
650 0 4 _aHumans
650 0 4 _aIndoleamine-Pyrrole 2,3,-Dioxygenase
_xphysiology
650 0 4 _aInterferon-gamma
_xphysiology
650 0 4 _aLupus Erythematosus, Systemic
_ximmunology
650 0 4 _aMesenchymal Stem Cell Transplantation
700 1 _aFeng, Xuebing
700 1 _aLu, Lin
700 1 _aKonkel, Joanne E
700 1 _aZhang, Huayong
700 1 _aChen, Zhiyong
700 1 _aLi, Xia
700 1 _aGao, Xiang
700 1 _aLu, Liwei
700 1 _aShi, Songtao
700 1 _aChen, Wanjun
700 1 _aSun, Lingyun
773 0 _tArthritis & rheumatology (Hoboken, N.J.)
_gvol. 66
_gno. 8
_gp. 2234-45
856 4 0 _uhttps://doi.org/10.1002/art.38674
_zAvailable from publisher's website
999 _c23760556
_d23760556